Pediatric Spitzoid Melanoma: A Case Report
DOI:
https://doi.org/10.5644/ama2006-124.482Keywords:
Melanoma, Spitz Tumor, Child, GenomicsAbstract
Objective. To highlight the diagnostic and therapeutic challenges of Spitzoid melanoma in childhood, with a focus on its potential genetic predisposition.
Case Report. A 7-year-old female patient presented with a growing nodular lesion on her upper leg. Excision was performed, and histopathological analysis confirmed a diagnosis of Spitzoid melanoma, classified as pT2a. Following a multidisciplinary review, wide local re-excision and sentinel lymph node biopsy (SLNB) were recommended. No re- sidual tumor was found, and the SLNB was negative. A comprehensive diagnostic evaluation ruled out systemic disease, and no additional treatment was required. Germline genetic testing identified a pathogenic CHEK2 variant (c.444+1G>A), prompting recommendations for genetic counseling and close follow-up.
Conclusion. This case report contributes to the limited body of knowledge on pediatric Spitzoid melanomas and underscores the importance of genetic insights in guiding both diagnostic and treatment decisions. The detection of a CHEK2 mutation underscores the importance of genetic profiling in family counseling
References
Sainz-Gaspar L, Sánchez-Bernal J, Noguera-Morel L, Hernández-Martín A, Colmenero I, Torrelo A. Spitz Nevus and Other Spitzoid Tumors in Children -Part 1: Clinical, Histopathologic, and Immunohistochemical Features. Actas Dermosifiliogr (Engl Ed). 2020;111(1):7-19.
Raghavan SS, Peternel S, Mully TW, North JP, Pincus LB, LeBoit PE, et al. Spitz melanoma is a distinct subset of spitzoid melanoma. Mod Pathol. 2020;33(6):1122-34. doi: 10.1038/s41379-019-0445-z. Epub 2020 Jan 3.
Wiesner T, Kutzner H, Cerroni L, Mihm MC Jr, Busam KJ, Murali R. Genomic aberrations in spitzoid melanocytic tumours and their implications for diagnosis, prognosis and therapy. Pathology. 2016;48(2):113-31. doi: 10.1016/j. pathol.2015.12.007. Epub 2016 Jan 18.
Barnhill RL, Kim J. Spitz nevus, atypical Spitz tumor (Spitz melanocytoma), and Spitz melanoma. UpToDate. 2024 Oct [cited 2025 May 1]. Available from: https:// www.uptodate.com/contents/spitz-nevus-atypical-spitz- tumor-spitz-melanocytoma-and-spitz-melanoma.
Fortarezza F, Cazzato G, Ingravallo G, Dei Tos AP. The 2023 WHO updates on skin tumors: advances since the 2018 edition. Pathologica. 2024;116(4):193-206. doi: 10.32074/1591-951X-1006.
LeBoit PE. Spitz melanoma. Clin Derma- tol. 2025;43(3):348-55. doi: 10.1016/j.clindermatol.2024.09.010. Epub 2024 Sep 13.
Asadbeigi SN, Yu Z. Spitz Melanoma of Childhood: A Review Compendium and Terminology Clarification. J Clin Transl Pathol. 2023;3(4):178-83. doi: 10.14218/ JCTP.2023.00023.
Merkel EA, Mohan LS, Shi K, Panah E, Zhang B, Gerami P. Paediatric melanoma: clinical update, genetic basis, and advances in diagnosis. Lancet Child Adolesc Health. 2019;3(9):646-54. doi: 10.1016/S2352-4642(19)30116-6. Epub 2019 Jun 13.
Cerrato F, Wallins JS, Webb ML, McCarty ER, Schmidt BA, Labow BI. Outcomes in pediatric atypical spitz tu- mors treated without sentinel lymph node biopsy. Pediatr Dermatol. 2012;29(4):448-53. doi: 10.1111/j.1525- 1470.2011.01699.x. Epub 2011 Dec 30.
Batra S. Spitzoid melanoma of childhood: a case series and review. Melanoma Manag. 2015;2(2):121-5. doi: 10.2217/ mmt.15.6. Epub 2015 May 18.
Goldstein AM, Qin R, Chu EY, Elder DE, Massi D, Adams DJ, et al. Association of germline variants in telomere maintenance genes (POT1, TERF2IP, ACD, and TERT) with spitzoid morphology in familial melanoma: A multi-center case series. JAAD Int. 2023;11:43-51. doi: 10.1016/j.jdin.2023.01.013.
Stolarova L, Kleiblova P, Janatova M, Soukupova J, Zemankova P, Macurek L, et al. CHEK2 Germline Variants in Cancer Predisposition: Stalemate Rather than Check- mate. Cells. 2020;9(12):2675. doi: 10.3390/cells9122675.
Bui AN, LeBoeuf NR, Nambudiri VE. Skin cancer risk in CHEK2 mutation carriers. J Eur Acad Dermatol Venereol. 2021;35(2):353-9. doi: 10.1111/jdv.16729. Epub 2020 Jul 8.
Weischer M, Heerfordt IM, Bojesen SE, Eigentler T, Garbe C, Röcken M, et al. CHEK2*1100delC and risk of malignant melanoma: Danish and German studies and meta-analysis. J Invest Dermatol. 2012;132(2):299-303. doi: 10.1038/jid.2011.303. Epub 2011 Sep 29.
Stolarova L, Jelinkova S, Storchova R, Machackova E, Zemankova P, Vocka M, et al. Identification of Germline Mutations in Melanoma Patients with Early Onset, Double Primary Tumors, or Family Cancer History by NGS Analysis of 217 Genes. Biomedicines. 2020;8(10):404. doi: 10.3390/biomedicines8100404.
Downloads
Published
License
Copyright (c) 2025 Jelena Roganović, Mia Radošević, Andrea Dekanić
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
